Tonix Pharmaceuticals Holding Corp. 4
4 · Tonix Pharmaceuticals Holding Corp. · Filed Dec 17, 2014
Insider Transaction Report
Form 4
GERSHELL LELAND
CFO and Treasurer
Transactions
- Exercise of In-Money
Common Stock, $0.001 par value
2014-12-17$4.25/sh+3,530$15,003→ 12,860 total - Exercise of In-Money
Series A common stock purchase warrant
2014-12-17−3,530→ 0 totalExercise: $4.25From: 2013-08-14Exp: 2018-08-14→ common stock (3,530 underlying)